MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment

European Journal of Pharmacology

Volumn 670, Issue 1, 2011, Pages 74-84

  Azzariti, Amalia ^a   Quatrale, Anna E ^a   Porcelli, Letizia ^a   Colabufo, Nicola A ^b   Cantore, Mariangela ^b   Cassano, Giuseppe ^b   Gasparre, Giuseppe ^b   Iannelli, Giuseppina ^a   Tommasi, Stefania ^a   Panaro, Maria A ^b   Paradiso, Angelo ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

ABCB1; ABCG2; Breast cancer; Colon cancer; CPT 11; Doxorubicin; MC70; Topotecan

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C1; BREAST CANCER RESISTANCE PROTEIN; DOXORUBICIN; IRINOTECAN; MC 70; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN INHIBITOR; PROTEIN KINASE B; SIGMA 1 OPIATE RECEPTOR; TOPOTECAN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; TARGET CELL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIPHENYL COMPOUNDS; BREAST NEOPLASMS; CAMPTOTHECIN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DOXORUBICIN; DRUG SYNERGISM; FEMALE; GENOMICS; HUMANS; KINETICS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NECROSIS; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TETRAHYDROISOQUINOLINES; TOPOTECAN;

EID: 80054732928     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.08.025     Document Type: Article

References (40)

1. J.D. Allen, and A.H. Schinkel Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2) Mol. Cancer Ther. 1 2002 427 434
2. G.A. Altenberg, C.G. Vanoye, E.S. Han, J.W. Deitmer, and L. Reuss Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein J. Biol. Chem. 269 1994 7145 7149
3. A. Atlante, S. Giannattasio, A. Bobba, S. Gagliardi, V. Petragallo, P. Calissano, E. Marra, and S. Passarella An increase in the ATP levels occurs in cerebellar granule cells en route to apoptosis in which ATP derives from both oxidative phosphorylation and anaerobic glycolysis Biochim. Biophys. Acta. 1708 2005 50 62 10.1016/j.bbabio.2005.01.009 (Pubitemid 40798530)
4. A. Azzariti, N.A. Colabufo, F. Berardi, L. Porcelli, M. Niso, G.M. Simone, R. Perrone, and A. Paradiso Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer Mol. Cancer Ther. 5 2006 1807 1816 10.1158/1535-7163.MCT-05-0402 (Pubitemid 44323249)
5. A. Azzariti, L. Porcelli, G. Gatti, A. Nicolin, and A. Paradiso Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells Biochem. Pharmacol. 75 2008 1035 1044 10.1016/j.bcp. 2007.11.018
6. E. Bernt, and H. Bergmeyer Lactate dehydrogenase H.U. Bergmeyer, Anonymous 1963 Academic Press London 736 741
7. V. Bevilacqua, P. Pannarale, G. Mastronardi, A. Azzariti, S. Tommasi, F. Menolascina, F. Iorio, D. Di Bernardo, A. Paradiso, N. Colabufo, F. Berardi, R. Perrone, and R. Tagliaferri High-throughput analysis of the drug mode of action of PB28, MC18 and MC70, three cyclohexylpiperazine derivative new molecules Book: "Advanced Intelligent Computing Theories and Applications: With Aspects of Artificial Intelligence" 2008 Springer Berlin/Heigelberg
8. C.J. Chen, J.E. Chin, K. Ueda, D.P. Clark, I. Pastan, M.M. Gottesman, and I.B. Roninson Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 1986 381 389 (Pubitemid 17210152)
9. S. Chevillard, P. Pouillart, C. Beldjord, B. Asselain, P. Beuzeboc, H. Magdelenat, and P. Vielh Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy Cancer 77 1996 292 300 2-X (Pubitemid 26023348)
10. H.C. Chung, S.Y. Rha, J.H. Kim, J.K. Roh, J.S. Min, K.S. Lee, B.S. Kim, and K.B. Lee P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer Breast Cancer Res. Treat. 42 1997 65 72 (Pubitemid 27056729)
11. N.A. Colabufo, F. Berardi, M. Cantore, M.G. Perrone, M. Contino, C. Inglese, M. Niso, R. Perrone, A. Azzariti, G.M. Simone, and A. Paradiso 4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators Bioorg. Med. Chem. 16 2008 3732 3743 10.1016/j.bmc.2008.01.055 (Pubitemid 351484037)
12. N.A. Colabufo, F. Berardi, M. Cantore, M.G. Perrone, M. Contino, C. Inglese, M. Niso, R. Perrone, A. Azzariti, G.M. Simone, L. Porcelli, and A. Paradiso Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives Bioorg. Med. Chem. 16 2008 362 373 10.1016/j.bmc.2007.09.039
13. S.P. Cole, and R.G. Deeley Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP Bioessays 20 1998 931 940 2-J (Pubitemid 28554038)
14. U. Consoli, A. Santonocito, F. Stagno, P. Fiumara, A. Privitera, G. Parisi, G.M. Giustolisi, B. Pavone, G.A. Palumbo, F. Di Raimondo, G. Milone, P. Guglielmo, and R. Giustolisi Multidrug resistance mechanisms in chronic lymphocytic leukaemia Br. J. Haematol. 116 2002 774 780 (Pubitemid 34226995)
15. J.E. Diestra, G.L. Scheffer, I. Catala, M. Maliepaard, J.H. Schellens, R.J. Scheper, J.R. Germa-Lluch, and M.A. Izquierdo Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material J. Pathol. 198 2002 213 219 10.1002/path.1203 (Pubitemid 35243879)
16. Z. Duan, E. Choy, and F.J. Hornicek NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance PLoS. One 4 2009 e7415 10.1371/journal.pone.0007415
17. O. Eidelman, and Z.I. Cabantchik Fluorescence methods for continuous monitoring of transport in cells and vesicles Methods Enzymol. 172 1989 122 135 (Pubitemid 19170350)
18. B. Feng, J.B. Mills, R.E. Davidson, R.J. Mireles, J.S. Janiszewski, M.D. Troutman, and S.M. de Morais In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system Drug Metab. Dispos. 36 2008 268 275 10.1124/dmd.107.017434 (Pubitemid 351185738)
19. D.R. Ferry, H. Traunecker, and D.J. Kerr Clinical trials of P-glycoprotein reversal in solid tumours Eur. J. Cancer 32A 1996 1070 1081
20. M. Filipits, R.W. Suchomel, G. Dekan, K. Haider, G. Valdimarsson, D. Depisch, and R. Pirker MRP and MDR1 gene expression in primary breast carcinomas Clin. Cancer Res. 2 1996 1231 1237 (Pubitemid 26238456)
21. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J.Y. Yang, and J. Zhang Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5 2004 R80 10.1186/gb-2004-5-10-r80
22. K. Han, J. Kahng, M. Kim, J. Lim, Y. Kim, B. Cho, H.K. Kim, W.S. Min, C.C. Kim, K.Y. Lee, B.K. Kim, and C.S. Kang Expression of functional markers in acute nonlymphoblastic leukemia Acta. Haematol. 104 2000 174 180 (Pubitemid 32250131)
23. S.B. Kaye Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention Curr. Opin. Oncol. 10 Suppl 1 1998 S15 S19
24. I. Kikuchi, Y. Nakayama, T. Morinaga, Y. Fukumoto, and N. Yamaguchi A decrease in cyclin B1 levels leads to polyploidization in DNA damage-induced senescence Cell. Biol. Int. 34 2010 645 653
25. C.P. Leith, K.J. Kopecky, I.M. Chen, L. Eijdems, M.L. Slovak, T.S. McConnell, D.R. Head, J. Weick, M.R. Grever, F.R. Appelbaum, and C.L. Willman Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study Blood 94 1999 1086 1099 (Pubitemid 29361842)
26. X. Lin, and W.G. Nelson Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells Cancer Res. 63 2003 498 504 (Pubitemid 36152513)
27. V. Megalizzi, V. Mathieu, T. Mijatovic, P. Gailly, O. Debeir, N. De Neve, M. Van Damme, G. Bontempi, B. Haibe-Kains, C. Decaestecker, Y. Kondo, R. Kiss, and F. Lefranc 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs Neoplasia 9 2007 358 369 (Pubitemid 46799979)
28. S. Nobili, I. Landini, B. Giglioni, and E. Mini Pharmacological strategies for overcoming multidrug resistance Curr. Drug Targets 7 2006 861 879
29. K. Nooter, H. Burger, and G. Stoter Multidrug resistance-associated protein (MRP) in haematological malignancies Leuk. Lymphoma 20 1996 381 387 (Pubitemid 26096043)
30. A. Rebbaa, X. Zheng, P.M. Chou, and B.L. Mirkin Caspase inhibition switches doxorubicin-induced apoptosis to senescence Oncogene 22 2003 2805 2811 10.1038/sj.onc.1206366 (Pubitemid 36609594)
31. G.L. Scheffer, M. Maliepaard, A.C. Pijnenborg, M.A. van Gastelen, M.C. de Jong, A.B. Schroeijers, D.M. van der Kolk, J.D. Allen, D.D. Ross, P. van der Valk, W.S. Dalton, J.H. Schellens, and R.J. Scheper Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines Cancer Res. 60 2000 2589 2593 (Pubitemid 30318229)
32. A. Seelig, and E. Gatlik-Landwojtowicz Inhibitors of multidrug efflux transporters: their membrane and protein interactions Mini Rev. Med. Chem. 5 2005 135 151 (Pubitemid 40305726)
33. J.M. Stempak, K.J. Sohn, E.P. Chiang, B. Shane, and Y.I. Kim Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model Carcinogenesis 26 2005 981 990 10.1093/carcin/bgi037 (Pubitemid 41214328)
34. K. Takara, T. Sakaeda, and K. Okumura An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy Curr. Pharm. Des. 12 2006 273 286
35. B.J. Trock, F. Leonessa, and R. Clarke Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance J. Natl. Cancer Inst. 89 1997 917 931 (Pubitemid 27282064)
36. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. USA 98 2001 5116 5121 10.1073/pnas.091062498 (Pubitemid 32397092)
37. H. Wang, Y. Ye, J.H. Chui, G.Y. Zhu, Y.W. Li, D.W. Fong, and Z.L. Yu Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells Oncol. Rep. 24 2010 647 651
38. L. Yang, T.Y. Besschetnova, C.R. Brooks, J.V. Shah, and J.V. Bonventre Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury Nat. Med. 16 2010 535 543 10.1038/nm.2144 1p following 143
39. T. Yokochi, and K.D. Robertson Doxorubicin inhibits DNMT1, resulting in conditional apoptosis Mol. Pharmacol. 66 2004 1415 1420 10.1124/mol.104.002634 (Pubitemid 39564768)
40. L.C. Young, B.G. Campling, T. Voskoglou-Nomikos, S.P. Cole, R.G. Deeley, and J.H. Gerlach Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response Clin. Cancer. Res. 5 1999 673 680 (Pubitemid 29131979)